Everence Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $955K | Hold |
1,700
| – | – | 0.06% | 248 |
|
|
2025
Q4 | $1.15M | Hold |
1,700
| – | – | 0.07% | 222 |
|
|
2025
Q3 | $1.09M | Hold |
1,700
| – | – | 0.07% | 221 |
|
|
2025
Q2 | $912K | Hold |
1,700
| – | – | 0.06% | 246 |
|
|
2025
Q1 | $714K | Hold |
1,700
| – | – | 0.05% | 287 |
|
|
2024
Q4 | $703K | Hold |
1,700
| – | – | 0.05% | 287 |
|
|
2024
Q3 | $859K | Sell |
1,700
-1,340
| -44% | -$651K | 0.05% | 266 |
|
|
2024
Q2 | $1.5K | Hold |
3,040
| – | – | 0.1% | 174 |
|
|
2024
Q1 | $1.64K | Hold |
3,040
| – | – | 0.11% | 172 |
|
|
2023
Q4 | $1.69M | Hold |
3,040
| – | – | 0.12% | 160 |
|
|
2023
Q3 | $1.33K | Buy |
3,040
+680
| +29% | +$339K | 0.1% | 164 |
|
|
2023
Q2 | $1.1M | Hold |
2,360
| – | – | 0.09% | 196 |
|
|
2023
Q1 | $1.18K | Buy |
2,360
+660
| +39% | +$316K | 0.1% | 182 |
|
|
2022
Q4 | $694 | Sell |
1,700
-360
| -17% | -$140K | 0.06% | 278 |
|
|
2022
Q3 | $671K | Hold |
2,060
| – | – | 0.06% | 267 |
|
|
2022
Q2 | $723K | Hold |
2,060
| – | – | 0.06% | 246 |
|
|
2022
Q1 | $1.13M | Hold |
2,060
| – | – | 0.09% | 188 |
|
|
2021
Q4 | $1.36M | Hold |
2,060
| – | – | 0.1% | 180 |
|
|
2021
Q3 | $1.28M | Hold |
2,060
| – | – | 0.11% | 164 |
|
|
2021
Q2 | $1.3M | Hold |
2,060
| – | – | 0.11% | 166 |
|
|
2021
Q1 | $1.01M | Hold |
2,060
| – | – | 0.09% | 186 |
|
|
2020
Q4 | $1.03M | Hold |
2,060
| – | – | 0.1% | 165 |
|
|
2020
Q3 | $810K | Hold |
2,060
| – | – | 0.09% | 183 |
|
|
2020
Q2 | $636K | Hold |
2,060
| – | – | 0.07% | 221 |
|
|
2020
Q1 | $499K | Hold |
2,060
| – | – | 0.07% | 239 |
|
|
2019
Q4 | $538K | Hold |
2,060
| – | – | 0.08% | 267 |
|
|
2019
Q3 | $560K | Hold |
2,060
| – | – | 0.09% | 234 |
|
|
2019
Q2 | $567K | Hold |
2,060
| – | – | 0.09% | 227 |
|
|
2019
Q1 | $461K | Hold |
2,060
| – | – | 0.08% | 272 |
|
|
2018
Q4 | $383K | Hold |
2,060
| – | – | 0.09% | 244 |
|
|
2018
Q3 | $514K | Hold |
2,060
| – | – | 0.1% | 218 |
|
|
2018
Q2 | $449K | Hold |
2,060
| – | – | 0.09% | 243 |
|
|
2018
Q1 | $394K | Hold |
2,060
| – | – | 0.09% | 254 |
|
|
2017
Q4 | $322K | Buy |
+2,060
| New | +$324K | 0.07% | 285 |
|
Other funds holding IDXX
VCM
VPM
Everence Capital Management's IDXX Position: Q1 2026 in Review
Everence Capital Management held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 1,700 shares worth $955K. The position accounts for 0.06% of the portfolio, ranked #248.
Everence Capital Management first reported a position in IDXX in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.69M in Q4 2023. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Everence Capital Management held 1,700 shares of Idexx Laboratories worth $955K as of Q1 2026.
- Everence Capital Management left its Idexx Laboratories share count unchanged in Q1 2026.
- Idexx Laboratories made up 0.06% of Everence Capital Management's portfolio in Q1 2026, its #248 holding.
- Everence Capital Management first reported a position in Idexx Laboratories in Q4 2017 and has held it in 34 quarters since.
- Everence Capital Management's Idexx Laboratories position peaked at $1.69M in Q4 2023.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.